Having trouble accessing articles? Reset your cache.

Cypress Bioscience, Ramius LLC deal

For the second time, Cypress' board rejected an unsolicited acquisition offer from shareholder Ramius LLC. In a letter dated Aug. 11, Ramius reiterated

Read the full 237 word article

User Sign In

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE